Es gab 50 kürzliche Insider-Transaktionen für Zentalis Pharmaceuticals, Inc. (ZNTL), darunter 28 Käufe und 16 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $26.73M und die gesamten Insider-Verkäufe auf $10.59M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Vultaggio Vincent, Eastland Julia Marie, Bruns Ingmar. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — ZNTL
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-10 |
Vultaggio Vincent |
Pao and Pfo |
Informierter Verkauf |
6,894 |
$2.42 |
$16.7K |
146,506 |
| 2026-02-09 |
Eastland Julia Marie |
CEO & President |
Informierter Verkauf |
889 |
$2.39 |
$2.13K |
79,133 |
| 2026-02-09 |
Bruns Ingmar |
Chief Medical Officer |
Informierter Verkauf |
335 |
$2.39 |
$801.62 |
33,332 |
| 2026-02-09 |
Vultaggio Vincent |
Pao and Pfo |
Informierter Verkauf |
3,379 |
$2.39 |
$8.09K |
153,400 |
| 2026-02-06 |
Eastland Julia Marie |
CEO & President |
Informierter Verkauf |
7,866 |
$2.43 |
$19.11K |
80,022 |
| 2026-02-06 |
Bruns Ingmar |
Chief Medical Officer |
Informierter Verkauf |
2,962 |
$2.43 |
$7.2K |
33,667 |
| 2026-02-06 |
Vultaggio Vincent |
Pao and Pfo |
Informierter Verkauf |
29,951 |
$2.43 |
$72.77K |
156,779 |
| 2026-02-03 |
Vultaggio Vincent |
Pao and Pfo |
Informierter Verkauf |
556 |
$2.52 |
$1.4K |
186,730 |
| 2026-02-02 |
Vultaggio Vincent |
Pao and Pfo |
Informierter Verkauf |
2,540 |
$2.55 |
$6.48K |
187,286 |
| 2026-01-08 |
Eastland Julia Marie |
CEO & President |
RSU-Zuteilung |
775,000 |
$2.84 |
$2.2M |
775,000 |
| 2026-01-08 |
Bucher James B |
Chief Legal Officer |
RSU-Zuteilung |
100,000 |
$2.84 |
$284K |
100,000 |
| 2026-01-08 |
Bruns Ingmar |
Chief Medical Officer |
RSU-Zuteilung |
365,000 |
$2.84 |
$1.04M |
365,000 |
| 2026-01-08 |
Vultaggio Vincent |
Pao and Pfo |
RSU-Zuteilung |
100,000 |
$2.84 |
$284K |
100,000 |
| 2025-12-31 |
Walters Group |
10 Percent Owner |
Informierter Kauf |
6,459,973 |
$1.20 |
$7.75M |
13,509,973 |
| 2025-12-15 |
Walters Group |
10 Percent Owner |
Unbekannt |
- |
- |
- |
7,050,000 |
| 2025-12-15 |
Matrix Capital Management Company, Lp |
10 Percent Owner |
Informierter Verkauf |
7,500,000 |
$1.33 |
$9.98M |
6,459,973 |
| 2025-10-01 |
Bucher James B |
Chief Legal Officer |
RSU-Zuteilung |
400,000 |
$1.54 |
$616K |
400,000 |
| 2025-09-18 |
Bucher James B |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-06-17 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
57,603 |
- |
- |
338,795 |
| 2025-06-17 |
Walker Luke Nathaniel |
Director |
RSU-Zuteilung |
57,603 |
- |
- |
144,284 |
| 2025-06-17 |
Johnson David Michael |
Director |
RSU-Zuteilung |
57,603 |
- |
- |
250,421 |
| 2025-06-17 |
Skvarka Jan |
Director |
RSU-Zuteilung |
57,603 |
- |
- |
207,154 |
| 2025-06-17 |
Kariuki Enoch |
Director |
RSU-Zuteilung |
57,603 |
- |
- |
137,365 |
| 2025-04-30 |
Myers Scott Dunseth |
Director |
Informierter Kauf |
21,000 |
$1.40 |
$29.37K |
281,192 |
| 2025-02-06 |
Bruns Ingmar |
Chief Medical Officer |
Informierter Kauf |
20,000 |
$2.28 |
$45.66K |
36,629 |
| 2025-02-03 |
Eastland Julia Marie |
CEO & President |
RSU-Zuteilung |
59,388 |
$1.68 |
$99.77K |
59,388 |
| 2025-02-03 |
Lackner Mark |
Chief Scientific Officer |
RSU-Zuteilung |
124,714 |
$1.68 |
$209.52K |
124,714 |
| 2025-02-03 |
Bruns Ingmar |
Chief Medical Officer |
RSU-Zuteilung |
16,629 |
$1.68 |
$27.94K |
16,629 |
| 2025-02-03 |
Paul Andrea |
Chief Legal Officer |
RSU-Zuteilung |
124,714 |
$1.68 |
$209.52K |
124,714 |
| 2025-02-03 |
Vultaggio Vincent |
Pao and Interim Pfo |
RSU-Zuteilung |
35,633 |
$1.68 |
$59.86K |
35,633 |
| 2025-01-31 |
Eastland Julia Marie |
CEO & President |
Informierter Kauf |
28,500 |
$1.73 |
$49.34K |
28,500 |
| 2025-01-31 |
Walker Luke Nathaniel |
Director |
Informierter Kauf |
14,200 |
$1.76 |
$24.97K |
86,681 |
| 2025-01-31 |
Skvarka Jan |
Director |
Informierter Kauf |
60,000 |
$1.72 |
$103.45K |
149,551 |
| 2025-01-02 |
Lackner Mark |
Chief Scientific Officer |
Informierter Verkauf |
4,411 |
$3.12 |
$13.76K |
191,317 |
| 2024-12-02 |
Eastland Julia Marie |
CEO & President |
RSU-Zuteilung |
3,028,800 |
$3.66 |
$11.09M |
3,028,800 |
| 2024-12-02 |
Bruns Ingmar |
Chief Medical Officer |
RSU-Zuteilung |
712,650 |
$3.66 |
$2.61M |
712,650 |
| 2024-11-13 |
Myers Scott Dunseth |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-11-13 |
Myers Scott Dunseth |
Director |
RSU-Zuteilung |
260,192 |
- |
- |
260,192 |
| 2024-11-13 |
Eastland Julia Marie |
CEO & President |
Unbekannt |
- |
- |
- |
- |
| 2024-11-13 |
Bruns Ingmar |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-10-04 |
Vultaggio Vincent |
Principal Accounting Officer |
Informierter Verkauf |
1,603 |
$3.18 |
$5.1K |
33,855 |
| 2024-06-21 |
Johnson David Michael |
Director |
RSU-Zuteilung |
48,429 |
- |
- |
192,818 |
| 2024-06-21 |
Skvarka Jan |
Director |
RSU-Zuteilung |
41,581 |
- |
- |
89,551 |
| 2024-06-21 |
Kariuki Enoch |
Director |
RSU-Zuteilung |
41,581 |
- |
- |
79,762 |
| 2024-05-31 |
Gallagher Cam |
President, Interim CFO |
Informierter Verkauf |
9,597 |
$11.98 |
$114.97K |
633,680 |
| 2024-05-24 |
Walker Luke Nathaniel |
Director |
Unbekannt |
- |
- |
- |
- |
| 2024-05-24 |
Walker Luke Nathaniel |
Director |
RSU-Zuteilung |
72,481 |
- |
- |
72,481 |
| 2024-05-09 |
Hausman Diana |
Chief Medical Officer |
Informierter Verkauf |
3,356 |
$12.62 |
$42.35K |
373,876 |
| 2024-04-05 |
Vultaggio Vincent |
Principal Accounting Officer |
Veräußerung |
25,000 |
$11.69 |
$292.25K |
- |
| 2024-02-12 |
Gallagher Cam |
President |
Informierter Verkauf |
1,173 |
$11.44 |
$13.42K |
643,277 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
